论文部分内容阅读
自从二十世纪五十年代中期,急性心肌梗塞(AMI)发生后血液中AST 和LDH 升高的报道问世以来,对于AMI 的诊断,血浆酶测定一直起着主要作用。近年来,随着常规溶栓治疗的采用,要求在AMI 症状出现后起初几小时内,提供可靠的AMI 标记物和无损伤的血管开放的指征。心脏酶和同工酶目前采用的AMI 的生化标记物中,肌酸激酶(CK)的MB 同工酶分析最为可靠,使用最广。MB-CK 在心脏中含量高,约占胞
Since the advent of reports of elevated levels of AST and LDH in the blood following acute myocardial infarction (AMI) in the mid-1950s, plasma enzyme assays have been of prime importance in the diagnosis of AMI. In recent years, with the adoption of conventional thrombolytic therapy, it has been required to provide reliable indications of AMI markers and non-invasive blood vessel opening within a few hours after the onset of AMI symptoms. Cardiac enzymes and isozymes Among the biochemical markers of AMI currently used, MB isoenzyme analysis of creatine kinase (CK) is the most reliable and widely used. MB-CK in the heart is high, accounting for about cells